BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 17175233)

  • 21. Evolution of glomerular basement membrane changes in chronic rejection.
    Yilmaz A; Yilmaz S; Kallio E; Rapola J; Häyry P
    Transplantation; 1995 Dec; 60(11):1314-22. PubMed ID: 8525527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of graft preservation and acute rejection on hypoxia-inducible factor-1 in rat cardiac allografts.
    Keränen MA; Nykänen AI; Krebs R; Tuuminen R; Sandelin H; Koskinen PK; Lemström KB
    Transplant Proc; 2006 Dec; 38(10):3372-3. PubMed ID: 17175275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of tissue factor (TF) in calcineurin inhibitor-induced nephrotoxicity and rejection--implications for development of a possible diagnostic marker.
    Osterholm C; Veress B; Simanaitis M; Hedner U; Ekberg H
    Transpl Immunol; 2005 Dec; 15(2):165-72. PubMed ID: 16412961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The changes of aquaporin 2 in the graft of acute rejection rat renal transplantation model.
    Chen B; Zang CS; Zhang JZ; Wang WG; Wang JG; Zhou HL; Fu YW
    Transplant Proc; 2010 Jun; 42(5):1884-7. PubMed ID: 20620543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute renal allograft rejection is associated with increased levels of vascular endothelial growth factor in the urine.
    Peng W; Chen J; Jiang Y; Shou Z; Chen Y; Wang H
    Nephrology (Carlton); 2008 Feb; 13(1):73-9. PubMed ID: 18199108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CMV increases tubular apoptosis through the TNF-alpha-TNF-R1 pathway in a rat model of chronic renal allograft rejection.
    Krogerus L; Soots A; Loginov R; Bruggeman C; Lautenschlager I
    Transpl Immunol; 2008 Jan; 18(3):232-6. PubMed ID: 18047930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sinomenine blocks tissue remodeling in a rat model of chronic cardiac allograft rejection.
    Mark W; Schneeberger S; Seiler R; Stroka DM; Amberger A; Offner F; Candinas D; Margreiter R
    Transplantation; 2003 Apr; 75(7):940-5. PubMed ID: 12698077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 3-Deazaadenosine prevents leukocyte invasion by suppression of adhesion molecule expression during acute cardiac allograft rejection: involvement of apoptotic cell death.
    Fingerhuth H; Hölschermann H; Grimm H; Tillmanns H; Haberbosch W; Braun-Dullaeus RC; Stadlbauer TH
    J Heart Lung Transplant; 2004 Aug; 23(8):970-8. PubMed ID: 15312827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early short-term imatinib treatment is sufficient to prevent the development of chronic allograft nephropathy.
    Savikko J; Rintala JM; Rintala SE; Koskinen PK; von Willebrand E
    Nephrol Dial Transplant; 2011 Sep; 26(9):3026-32. PubMed ID: 21285128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts.
    Nykänen AI; Sandelin H; Krebs R; Keränen MA; Tuuminen R; Kärpänen T; Wu Y; Pytowski B; Koskinen PK; Ylä-Herttuala S; Alitalo K; Lemström KB
    Circulation; 2010 Mar; 121(12):1413-22. PubMed ID: 20231530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sirolimus reduces vasculopathy but exacerbates proteinuria in association with inhibition of VEGF and VEGFR in a rat kidney model of chronic allograft dysfunction.
    Ko HT; Yin JL; Wyburn K; Wu H; Eris JM; Hambly BD; Chadban SJ
    Nephrol Dial Transplant; 2013 Feb; 28(2):327-36. PubMed ID: 23229928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late onset antibody-mediated rejection and endothelial localization of vascular endothelial growth factor are associated with development of cardiac allograft vasculopathy.
    Bayliss J; Bailey M; Leet A; Stein AN; Thomson NM; McLean CA
    Transplantation; 2008 Oct; 86(7):991-7. PubMed ID: 18852667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. FTY720, an immunosuppressant that alters lymphocyte trafficking, abrogates chronic rejection in combination with cyclosporine A.
    Koshiba T; Van Damme B; Rutgeerts O; Waer M; Pirenne J
    Transplantation; 2003 Apr; 75(7):945-52. PubMed ID: 12698078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1.
    Hazarika S; Dokun AO; Li Y; Popel AS; Kontos CD; Annex BH
    Circ Res; 2007 Oct; 101(9):948-56. PubMed ID: 17823371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expressions of Angiopoietin-1, Angiopoietin-2, and Tie2 and their roles in rat renal allografts with chronic allograft nephropathy.
    Ma X; Lu YP; Yang L; Song J; Luo GH; Shi YJ; Li YP
    Transplant Proc; 2008 Oct; 40(8):2795-9. PubMed ID: 18929864
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGFR-1 and -2 regulate inflammation, myocardial angiogenesis, and arteriosclerosis in chronically rejecting cardiac allografts.
    Raisky O; Nykänen AI; Krebs R; Hollmén M; Keränen MA; Tikkanen JM; Sihvola R; Alhonen L; Salven P; Wu Y; Hicklin DJ; Alitalo K; Koskinen PK; Lemström KB
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):819-25. PubMed ID: 17290032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunolocalization of VEGF, VEGFR-1 and VEGFR-2 in lung tissues after acute hemorrhage in rats.
    Ekerbicer N; Tarakci F; Barut T; Inan S
    Acta Histochem; 2008; 110(4):285-93. PubMed ID: 18321563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of FTY720 in rat small bowel transplantation: expression of mucosal addressin cell adhesion molecule-1.
    Sugito K; Koshinaga T; Inoue M; Ikeda T; Hagiwara N; Fukuzawa M
    Transplant Proc; 2005 Dec; 37(10):4472-4. PubMed ID: 16387148
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sirolimus inhibits lymphangiogenesis in rat renal allografts, a novel mechanism to prevent chronic kidney allograft injury.
    Palin NK; Savikko J; Koskinen PK
    Transpl Int; 2013 Feb; 26(2):195-205. PubMed ID: 23167600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of tumor necrosis factor-alpha attenuates myocardial remodeling in rat cardiac allografts.
    Sihvola RK; Koskinen PK; Pulkkinen VP; Tikkanen JM; Lemström KB
    J Heart Lung Transplant; 2006 May; 25(5):569-78. PubMed ID: 16678037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.